What is the dosing frequency and volume in milliliters for guaifenesin 100 mg/5 mL in an adult?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 15, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Guaifenesin 100mg/5mL Dosing for Adults

For adults, administer 10-20 mL (200-400 mg) of guaifenesin 100mg/5mL oral solution every 4 hours, not exceeding 6 doses in 24 hours. 1

Dosing Details

The FDA-approved dosing for guaifenesin 100mg/5mL oral solution in adults (≥12 years) is:

  • Volume per dose: 10-20 mL (equivalent to 2-4 teaspoonfuls)
  • Frequency: Every 4 hours
  • Maximum daily doses: 6 doses in any 24-hour period
  • Total daily dose range: 1200-2400 mg (60-120 mL) 1

Practical Considerations

Flexible dosing within the range allows titration based on symptom severity. The lower end (10 mL/200 mg) may be appropriate for mild symptoms, while the upper end (20 mL/400 mg) can be used for more significant mucus-related symptoms 2.

Multiple daily doses are necessary because immediate-release guaifenesin formulations require frequent administration to maintain therapeutic plasma concentrations throughout the day 2. Extended-release formulations are available that allow 12-hourly dosing if preferred for convenience 2.

Clinical Context

The evidence supporting guaifenesin's efficacy remains limited. While it is the only legally marketed expectorant in the US and has FDA approval, recent systematic reviews question whether it provides significant benefit over placebo for upper respiratory symptoms 3, 4. The 2025 AAO-HNS sinusitis guideline explicitly states "there is no evidence regarding the effect, if any, on symptomatic relief of ABRS" 3.

Despite these limitations, guaifenesin has a well-established safety profile with minimal adverse effects in adults 2. If used, it should be positioned as symptomatic therapy with realistic expectations about potential benefits.

Important Caveats

  • Do not exceed 6 doses (120 mL maximum) in 24 hours to avoid potential toxicity
  • The formulation is sugar-free and alcohol-free 1
  • Available in various bottle sizes (120 mL, 237 mL, 473 mL) and unit-dose cups 1
  • Consider that many patients may improve with supportive care alone, particularly in acute respiratory infections 3

References

Guideline

clinical practice guideline: adult sinusitis update.

Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery, 2025

Research

Guaifenesin: The Ubiquitous Orphan.

Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery, 2024

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.